vs
Side-by-side financial comparison of NETSTREIT Corp. (NTST) and STEM, INC. (STEM). Click either name above to swap in a different company.
NETSTREIT Corp. is the larger business by last-quarter revenue ($57.1M vs $47.1M, roughly 1.2× STEM, INC.). NETSTREIT Corp. runs the higher net margin — 10.0% vs -33.9%, a 43.9% gap on every dollar of revenue. On growth, NETSTREIT Corp. posted the faster year-over-year revenue change (24.3% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 20.1%).
NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
NTST vs STEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.1M | $47.1M |
| Net Profit | $5.7M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | 34.1% | -17.7% |
| Net Margin | 10.0% | -33.9% |
| Revenue YoY | 24.3% | -15.6% |
| Net Profit YoY | 235.9% | 68.8% |
| EPS (diluted) | $0.32 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $57.1M | — | ||
| Q4 25 | $52.5M | $47.1M | ||
| Q3 25 | $48.3M | $38.2M | ||
| Q2 25 | $48.3M | $38.4M | ||
| Q1 25 | $45.9M | $32.5M | ||
| Q4 24 | $44.1M | $55.8M | ||
| Q3 24 | $41.4M | $29.3M | ||
| Q2 24 | $39.6M | $34.0M |
| Q1 26 | $5.7M | — | ||
| Q4 25 | $1.3M | $-16.0M | ||
| Q3 25 | $618.0K | $-23.8M | ||
| Q2 25 | $3.3M | $202.5M | ||
| Q1 25 | $1.7M | $-25.0M | ||
| Q4 24 | $-5.4M | $-51.1M | ||
| Q3 24 | $-5.3M | $-148.3M | ||
| Q2 24 | $-2.3M | $-582.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% |
| Q1 26 | 34.1% | — | ||
| Q4 25 | 2.6% | -17.7% | ||
| Q3 25 | 1.3% | -33.6% | ||
| Q2 25 | 6.8% | -34.8% | ||
| Q1 25 | 3.7% | -65.0% | ||
| Q4 24 | -12.3% | -84.4% | ||
| Q3 24 | -12.8% | -493.2% | ||
| Q2 24 | -5.8% | -1705.5% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 2.5% | -33.9% | ||
| Q3 25 | 1.3% | -62.2% | ||
| Q2 25 | 6.8% | 527.8% | ||
| Q1 25 | 3.7% | -76.9% | ||
| Q4 24 | -12.3% | -91.6% | ||
| Q3 24 | -12.8% | -506.3% | ||
| Q2 24 | -5.8% | -1712.6% |
| Q1 26 | $0.32 | — | ||
| Q4 25 | $0.01 | $-4.40 | ||
| Q3 25 | $0.01 | $-2.84 | ||
| Q2 25 | $0.04 | $-1.79 | ||
| Q1 25 | $0.02 | $-0.15 | ||
| Q4 24 | $-0.07 | $-15.29 | ||
| Q3 24 | $-0.07 | $-18.24 | ||
| Q2 24 | $-0.03 | $-71.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $-249.4M |
| Total Assets | $2.8B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $926.6M | — | ||
| Q1 25 | $913.3M | — | ||
| Q4 24 | $868.3M | — | ||
| Q3 24 | $778.7M | — | ||
| Q2 24 | $726.2M | — |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.4B | $-249.4M | ||
| Q3 25 | $1.3B | $-235.7M | ||
| Q2 25 | $1.3B | $-214.1M | ||
| Q1 25 | $1.3B | $-417.5M | ||
| Q4 24 | $1.3B | $-398.4M | ||
| Q3 24 | $1.3B | $-344.1M | ||
| Q2 24 | $1.3B | $-203.2M |
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.6B | $308.9M | ||
| Q3 25 | $2.5B | $362.6M | ||
| Q2 25 | $2.3B | $379.2M | ||
| Q1 25 | $2.3B | $405.1M | ||
| Q4 24 | $2.3B | $437.4M | ||
| Q3 24 | $2.2B | $537.8M | ||
| Q2 24 | $2.1B | $691.5M |
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.84× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 0.65× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.55× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $109.5M | $8.2M | ||
| Q3 25 | $28.0M | $11.4M | ||
| Q2 25 | $30.6M | $-21.3M | ||
| Q1 25 | $22.1M | $8.5M | ||
| Q4 24 | $90.2M | $-14.7M | ||
| Q3 24 | $25.1M | $-9.4M | ||
| Q2 24 | $25.4M | $-11.9M |
| Q1 26 | — | — | ||
| Q4 25 | 82.46× | — | ||
| Q3 25 | 45.27× | — | ||
| Q2 25 | 9.36× | -0.11× | ||
| Q1 25 | 13.06× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |
STEM
Segment breakdown not available.
